Compare, Analyse Fresenius Kabi Onco. with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FRESENIUS KABI ONCO. vs ADCOCK INGRAM (S. Africa) - Comparison Results

FRESENIUS KABI ONCO.     Change

Fresenius Kabi Oncology is the erstwhile Dabur Pharma, which was incorporated in March 2003. The company is a leading player in oncology in India and the international markets. Fresenius Kabi Oncology operates in the regulated markets namely the US a... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 FRESENIUS KABI ONCO.   ADCOCK INGRAM
EQUITY SHARE DATA
    FRESENIUS KABI ONCO.
Mar-13
ADCOCK INGRAM
Jun-14
FRESENIUS KABI ONCO./
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs176347-   
Low Rs79251-   
Sales per share (Unadj.) Rs37.7103.3-  
Earnings per share (Unadj.) Rs5.1-26.0-  
Cash flow per share (Unadj.) Rs6.7-21.6-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs42.581.1-  
Shares outstanding (eoy) m158.23168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.42.9 116.7%   
Avg P/E ratio x25.0-11.5 -217.6%  
P/CF ratio (eoy) x18.9-13.9 -136.6%  
Price / Book Value ratio x3.03.7 81.1%  
Dividend payout %00-   
Avg Mkt Cap Rs m20,13550,448 39.9%   
No. of employees `0001.24.3 26.8%   
Total wages/salary Rs m7033,166 22.2%   
Avg. sales/employee Rs Th5,176.24,061.4 127.4%   
Avg. wages/employee Rs Th610.4737.5 82.8%   
Avg. net profit/employee Rs Th699.6-1,023.4 -68.4%   
INCOME DATA
Net Sales Rs m5,96317,436 34.2%  
Other income Rs m18122 14.7%   
Total revenues Rs m5,98117,558 34.1%   
Gross profit Rs m1,430-3,021 -47.3%  
Depreciation Rs m258753 34.3%   
Interest Rs m-26472 -5.5%   
Profit before tax Rs m1,216-4,124 -29.5%   
Minority Interest Rs m0-11 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-680-   
Tax Rs m342258 132.8%   
Profit after tax Rs m806-4,393 -18.3%  
Gross profit margin %24.0-17.3 -138.4%  
Effective tax rate %28.1-6.2 -450.3%   
Net profit margin %13.5-25.2 -53.6%  
BALANCE SHEET DATA
Current assets Rs m5,10212,770 39.9%   
Current liabilities Rs m2,3857,185 33.2%   
Net working cap to sales %45.632.0 142.2%  
Current ratio x2.11.8 120.3%  
Inventory Days Days150111 135.3%  
Debtors Days Days113124 91.4%  
Net fixed assets Rs m5,1487,444 69.2%   
Share capital Rs m15881 195.4%   
"Free" reserves Rs m6,5560-   
Net worth Rs m6,73213,685 49.2%   
Long term debt Rs m9524,809 19.8%   
Total assets Rs m10,38825,852 40.2%  
Interest coverage x-45.8-7.7 592.0%   
Debt to equity ratio x0.10.4 40.3%  
Sales to assets ratio x0.60.7 85.1%   
Return on assets %7.5-15.2 -49.5%  
Return on equity %12.0-32.1 -37.3%  
Return on capital %14.6-19.8 -73.7%  
Exports to sales %74.50-   
Imports to sales %24.80-   
Net fx Rs m3,5250-   
CASH FLOW
From Operations Rs m1,2741,488 85.6%  
From Investments Rs m-1,204-457 263.5%  
From Financial Activity Rs m-1964,365 -4.5%  
Net Cashflow Rs m-1265,396 -2.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.79 Rs / ZAR

Compare FRESENIUS KABI ONCO. With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare FRESENIUS KABI ONCO. With: ABBOTT INDIA  FDC LTD.  AUROBINDO PHARMA  IPCA LABS  PANACEA BIOTECH  



Today's Market

Indian Indices Trade Marginally Higher; FMCG Stocks Advance(12:30 pm)

Share markets in India are presently trading on a positive note. The BSE Sensex is trading up by 76 points while the NSE Nifty is trading up by 12 points.

Related Views On News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound? (The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

Rebound Riches Could be Yours With These Stocks (Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

FRESENIUS KABI ONCO. SHARE PRICE


Jan 2, 2014 (Close)

TRACK FRESENIUS KABI ONCO.

  • Track your investment in FRESENIUS KABI ONCO. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON FRESENIUS KABI ONCO.

FRESENIUS KABI ONCO. 5-YR ANALYSIS

COMPARE FRESENIUS KABI ONCO. WITH

MARKET STATS